BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1725670)

  • 41. Co-clustering of galactosylceramide and membrane proteins in oligodendrocyte membranes on interaction with polyvalent carbohydrate and prevention by an intact cytoskeleton.
    Boggs JM; Wang H
    J Neurosci Res; 2004 May; 76(3):342-55. PubMed ID: 15079863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo actions of fibroblast growth factor-2 and insulin-like growth factor-I on oligodendrocyte development and myelination in the central nervous system.
    Goddard DR; Berry M; Butt AM
    J Neurosci Res; 1999 Jul; 57(1):74-85. PubMed ID: 10397637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microtubule-associated protein MAP1B expression precedes the morphological differentiation of oligodendrocytes.
    Vouyiouklis DA; Brophy PJ
    J Neurosci Res; 1993 Jun; 35(3):257-67. PubMed ID: 8350387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes.
    Katsel P; Davis KL; Li C; Tan W; Greenstein E; Kleiner Hoffman LB; Haroutunian V
    Neuropsychopharmacology; 2008 Nov; 33(12):2993-3009. PubMed ID: 18322470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Localisation and expression of a myelin associated neurite inhibitor, Nogo-A and its receptor Nogo-receptor by mammalian CNS cells.
    Nyatia E; Lang DM
    Res Vet Sci; 2007 Dec; 83(3):287-301. PubMed ID: 17428512
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The number of cells expressing the myelin-supporting oligodendrocyte marker PLP-exon 3b remains unchanged in Wallerian degeneration.
    Li G; Blakemore WF
    J Neurotrauma; 2004 Aug; 21(8):1044-9. PubMed ID: 15319003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protein kinase C activity modulates myelin gene expression in enriched oligodendrocytes.
    Asotra K; Macklin WB
    J Neurosci Res; 1993 Apr; 34(5):571-88. PubMed ID: 7683060
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oligodendrocytes in aging mice lacking myelin-associated glycoprotein are dystrophic but not apoptotic.
    Weiss MD; Hammer J; Quarles RH
    J Neurosci Res; 2000 Dec; 62(6):772-80. PubMed ID: 11107161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extensive loss of connexins in Baló's disease: evidence for an auto-antibody-independent astrocytopathy via impaired astrocyte-oligodendrocyte/myelin interaction.
    Masaki K; Suzuki SO; Matsushita T; Yonekawa T; Matsuoka T; Isobe N; Motomura K; Wu XM; Tabira T; Iwaki T; Kira J
    Acta Neuropathol; 2012 Jun; 123(6):887-900. PubMed ID: 22438105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin-like growth factor I stimulates oligodendrocyte development and myelination in rat brain aggregate cultures.
    Mozell RL; McMorris FA
    J Neurosci Res; 1991 Oct; 30(2):382-90. PubMed ID: 1665869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of QKI proteins and MAP1B identifies actively myelinating oligodendrocytes in adult rat brain.
    Wu HY; Dawson MR; Reynolds R; Hardy RJ
    Mol Cell Neurosci; 2001 Feb; 17(2):292-302. PubMed ID: 11178867
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Production and isolation of NG2+ oligodendrocyte precursors from human embryonic stem cells in defined serum-free medium.
    Sundberg M; Skottman H; Suuronen R; Narkilahti S
    Stem Cell Res; 2010 Sep; 5(2):91-103. PubMed ID: 20538536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential regulation of basic protein phosphorylation by calcium phospholipid and cyclic-AMP-dependent protein kinases.
    Dawson G; McAtee P
    J Cell Biochem; 1989 Jul; 40(3):261-9. PubMed ID: 2777906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.
    Kerlero de Rosbo N; Milo R; Lees MB; Burger D; Bernard CC; Ben-Nun A
    J Clin Invest; 1993 Dec; 92(6):2602-8. PubMed ID: 7504688
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conversion of myelin-associated glycoprotein (MAG) to a smaller derivative by calcium activated neutral protease (CANP)-like enzyme in myelin and inhibition by E-64 analogue.
    Sato S; Yanagisawa K; Miyatake T
    Neurochem Res; 1984 May; 9(5):629-35. PubMed ID: 6206410
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phosphorylation of myelin-associated glycoprotein in vivo and in vitro occurs only in the cytoplasmic domain of the large isoform.
    Edwards AM; Braun PE; Bell JC
    J Neurochem; 1989 Jan; 52(1):317-20. PubMed ID: 2462021
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of myelin glycolipids and proteins in mitotic and postmitotic murine oligodendrocytes.
    Knapp PE; Skoff RP
    Ann N Y Acad Sci; 1991; 633():508-10. PubMed ID: 1789569
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effect of phorbol ester on the oligodendrocyte in culture].
    Sekiguchi S; Eto Y; Maekawa K; Su K
    No To Hattatsu; 1989 May; 21(3):296-8. PubMed ID: 2736130
    [No Abstract]   [Full Text] [Related]  

  • 59. The oligodendroglia cytoskeleton in health and disease.
    Richter-Landsberg C
    Springerplus; 2015; 4(Suppl 1):L15. PubMed ID: 27386177
    [No Abstract]   [Full Text] [Related]  

  • 60. Experimental alcohol-related peripheral neuropathy: role of insulin/IGF resistance.
    Nguyen VA; Le T; Tong M; Mellion M; Gilchrist J; de la Monte SM
    Nutrients; 2012 Aug; 4(8):1042-57. PubMed ID: 23016131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.